Nektar Therapeutics (NasdaqCM:NKTR) FY Conference Transcript

Nektar Therapeutics (NasdaqCM:NKTR) FY Conference September 10, 2025 10:30 AM ET Speaker0Get started. Good morning, everyone. Thanks for joining us today. My name is Arthur He, a senior biotech analyst at the HC Wainwright. Thanks for joining us to have a conversation with doctor Jonathan Zalevsky, chief r and d officer.A little bit about Nektar. Nektar is a global biopharmaceutical company focused on developing novel therapies that selectively moderate the immune system to treat autoimmune disorder by leve ...